GIST research

/Tag:GIST research

Innovative Approach in GIST Research in the Era of Precision Medicine

Columbia University Medical Center, New York-Presbyterian and the Life Raft Group have entered into a collaborative effort to advance research to find a cure for GIST using a novel therapeutic approach and patient-driven data. [...]

By | 2018-10-30T09:13:45+00:00 July 12th, 2017|Video, Webcast|

Latest Issue of the GIST and Sarcoma Journal is Now Available Online

The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals [...]

By | 2018-10-30T09:19:21+00:00 May 18th, 2017|News, Research|

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By | 2018-10-30T09:19:32+00:00 February 27th, 2017|News, Research|

Collaboration Lays the Groundwork for Breakthroughs in GIST

This article originally appeared in the January 30th edition of Cure Today. Less than two decades ago, Gleevec (imatinib) drastically changed the frontline treatment for patients with gastrointestinal stromal tumors (GIST). However, as patients [...]

By | 2018-10-30T09:20:36+00:00 February 24th, 2017|News, Newsletter, Research|

Study Highlights Role of ABL1 in GIST Treated with Imatinib

A recent study published in Oncotarget, discussed the potential role of the kinase, ABL1 as a potential impediment to anti-tumor processes in GIST treated with imatinib mesylate. The Life Raft Group’s Research Team member, [...]

By | 2018-10-30T09:23:31+00:00 January 19th, 2017|News, Research|

Update on Blueprint Medicines Clinical Trial for BLU-285

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

By | 2018-10-30T09:50:21+00:00 May 24th, 2016|Clinical Trials, News, Research|

Recent Posts

Upcoming Events

  1. GDOL Los Angeles 2019

    February 16, 2019 @ 8:00 AM - 5:00 PM